Shabnam M. Namin, PhD, MBA, CTBS Dr. Shab is the CEO of 42Bio, a start-up biotech company based out of Gainesville, FL. 42Bio is a leading company in several technologies such as the development of magnetic separation devices for biological materials, placenta-based cosmetics, and veterinarian medical products. She is the former VP of R&D-Operations for VIVEX Biologics, Inc. where she was responsible for leading product development of all cell and tissue-based and placenta-derived products for the company. Her main interests are the development of regenerative therapies and providing tools to increase research in the development of needed therapeutics. Dr. Shab received her Bachelors and PhD in Biomedical Engineering from Florida International University. In addition, she received an MBA and MS in Industrial Engineering from the University of Miami and an MS in Biotechnology from Harvard University. During her early studies, Dr. Shab spent several years working in many different facets in the tissue engineering realm, focusing on the commercialization of cell and tissue-based products. She has multiple publications and patents for her work on the development of these therapies. She is currently the Chair of the Scientific & Technical Affairs Committee (STAC) for the American Association of Tissue Banks.